Clinically, a high Ki-67 index may suggest a more aggressive tumor, influencing the decision to pursue neoadjuvant chemotherapy, especially in cases where other biomarkers present an ambiguous prognosis.4 The gene discussed is MKI67; the disease is neoplasm.